Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |